Human intestinal organoids from Cronkhite-Canada syndrome patients reveal link between serotonin and proliferation
Cronkhite-Canada Syndrome (CCS) is a rare, noninherited polyposis syndrome affecting 1 in every million individuals. Despite over 50 years of CCS cases, the etiopathogenesis and optimal treatment for CCS remains unknown due to the rarity of the disease and lack of model systems. To better understand...
| Published in: | The Journal of Clinical Investigation |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical Investigation
2023-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1172/JCI166884 |
